George Garibaldi

Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: Analysis of CATIE data

Jonathan Rabinowitz, Stephen Z. Levine, George Garibaldi et al. · Schizophrenia Research · 2012 · 368 citations

Medicine, Psychiatry, Psychology +12

Effect of Bitopertin, a Glycine Reuptake Inhibitor, on Negative Symptoms of Schizophrenia

Daniel Umbricht, Daniela Alberati, Meret Martin‐Facklam et al. · JAMA Psychiatry · 2014 · 230 citations

Medicine, Pharmacology, Psychiatry +16

Bitopertin in Negative Symptoms of Schizophrenia—Results From the Phase III FlashLyte and DayLyte Studies

Dragana Bugarski‐Kirola, Thomas Blaettler, Celso Arango et al. · Biological Psychiatry · 2016 · 139 citations

Medicine, Pharmacology, Psychiatry +13

Efficacy and safety of adjunctive bitopertin versus placebo in patients with suboptimally controlled symptoms of schizophrenia treated with antipsychotics: results from three phase 3, randomised, double-blind, parallel-group, placebo-controlled, multicentre studies in the SearchLyte clinical trial programme

Dragana Bugarski‐Kirola, Nakao Iwata, Snjezana Sameljak et al. · The Lancet Psychiatry · 2016 · 96 citations

Medicine, Pharmacotherapy, Psychiatry +17

A Randomized, Placebo-Controlled Study Investigating the Nicotinic α7 Agonist, RG3487, for Cognitive Deficits in Schizophrenia

Daniel Umbricht, Richard S.E. Keefe, Stephen A. Murray et al. · Neuropsychopharmacology · 2014 · 80 citations

Medicine, Neuroscience, Pharmacology +15